PAIN
Volume 137, Issue 2 , Pages 295-305 , 15 July 2008

Involvement of metabotropic glutamate 5 receptor in visceral pain

  • Erik Lindström

      Affiliations

    • AstraZeneca R&D, Mölndal, Sweden
    • Corresponding Author InformationCorresponding author. Present address: Medivir AB, Lunastigen 7, S-14122 Huddinge, Sweden. Tel.: +46 8 5468 3232.
    • ,
  • Mikael Brusberg

      Affiliations

    • AstraZeneca R&D, Mölndal, Sweden
    • ,
  • Patrick A. Hughes

      Affiliations

    • Nerve Gut Research Laboratory, Hanson Institute, Royal Adelaide Hospital, University of Adelaide, Australia
    • Discipline of Physiology, School of Molecular and Biomedical Sciences, University of Adelaide, Australia
    • ,
  • Christopher M. Martin

      Affiliations

    • Nerve Gut Research Laboratory, Hanson Institute, Royal Adelaide Hospital, University of Adelaide, Australia
    • ,
  • Stuart M. Brierley

      Affiliations

    • Nerve Gut Research Laboratory, Hanson Institute, Royal Adelaide Hospital, University of Adelaide, Australia
    • Discipline of Physiology, School of Molecular and Biomedical Sciences, University of Adelaide, Australia
    • ,
  • Benjamin D. Phillis

      Affiliations

    • Nerve Gut Research Laboratory, Hanson Institute, Royal Adelaide Hospital, University of Adelaide, Australia
    • Discipline of Physiology, School of Molecular and Biomedical Sciences, University of Adelaide, Australia
    • ,
  • Rakel Martinsson

      Affiliations

    • AstraZeneca R&D, Mölndal, Sweden
    • ,
  • Christina Abrahamsson

      Affiliations

    • AstraZeneca R&D, Mölndal, Sweden
    • ,
  • Håkan Larsson

      Affiliations

    • AstraZeneca R&D, Mölndal, Sweden
    • ,
  • Vicente Martinez

      Affiliations

    • AstraZeneca R&D, Mölndal, Sweden
    • ,
  • L. Ashley Blackshaw

      Affiliations

    • Nerve Gut Research Laboratory, Hanson Institute, Royal Adelaide Hospital, University of Adelaide, Australia
    • Discipline of Medicine, School of Molecular and Biomedical Sciences, University of Adelaide, Australia
    • Discipline of Physiology, School of Molecular and Biomedical Sciences, University of Adelaide, Australia

Received 27 April 2007 ,Revised 30 August 2007 ,Accepted 10 September 2007.

References 

  1. Anderson JJ, Bradbury MJ, Giracello DR, Chapman DF, Holtz G, Roppe J, et al. In vivo occupancy of mGlu5 receptor antagonists using the novel radioligand [3H]3-methoxy-5-(pyridin-2-ylethynyl)pyridine. Eur J Pharmacol. 2003;473:35–40
  2. Ango F, Prezeau L, Muller T, Tu JC, Xiao B, Worley PF, et al. Agonist-independent activation of metabotropic glutamate receptors by the intracellular protein Homer. Nature. 2001;411:962–965
  3. Arvidsson S, Brusberg M, Larsson M, Larsson H, Lindström E, Martinez V. CB1 receptors mediate the analgesic effects of cannabinoids on visceral pain in rodents. Neurogastro Motil 2005;17:20(abstract).
  4. Berthoud HR, Lynn PA, Blackshaw LA. Vagal and spinal mechanosensors in the rat stomach and colon have multiple receptive fields. Am J Physiol. 2001;280:R1371–R1381
  5. Bianchi R, Rezzani R, Borsani E, Rodella L. MGlu5 receptor antagonist decreases Fos expression in spinal neurons after noxious visceral stimulation. Brain Res. 2003;960:263–266
  6. Bhave G, Karim F, Carlton SM, Gereau RW. Peripheral group I metabotropic glutamate receptors modulate nociception in mice. Nat Neurosci. 2001;4:417–423
  7. Brierley SM, Jones RC, Gebhart GF, Blackshaw LA. Splanchnic and pelvic mechanosensory afferents signal different qualities of colonic stimuli in mice. Gastroenterology. 2004;127:166–178
  8. Cartmell J, Schoepp DD. Regulation of neurotransmitter release by metabotropic glutamate receptors. J Neurochem. 2000;75:889–907
  9. Chang L, Munakata J, Mayer EA, Schmulson MJ, Johnson TD, Bernstein CN, et al. Perceptual responses in patients with inflammatory and functional bowel disease. Gut. 2000;47:497–505
  10. Cosford ND, Tehrani L, Roppe J, Schweiger E, Smith ND, Anderson J, et al. 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity. J Med Chem. 2003;46:204–206
  11. Coutinho SV, Meller ST, Gebhart GF. Intracolonic zymosan produces visceral hyperalgesia in the rat that is mediated by spinal NMDA and non-NMDA receptors. Brain Res. 1996;736:7–15
  12. Dogrul A, Ossipov MH, Lai J, Malan TP, Porreca F. Peripheral and spinal antihyperalgesic activity of SIB-1757, a metabotropic glutamate receptor (mGLUR5) antagonist, in experimental neuropathic pain in rats. Neurosci Lett. 2000;292:115–118
  13. Fischer K, Lefebvre C, Coderre TJ. Antinociceptive effects following intrathecal pretreatment with selective metabotropic glutamate receptor compounds in a rat model of neuropathic pain. Pharmacol Biochem Behav. 2002;73:411–418
  14. Gasparini F, Lingenhohl K, Stoehr N, Flor PJ, Heinrich M, Vranesic I, et al. 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent selective and systemically active mGluR5 antagonist. Neuropharmacology. 1999;38:1493–1503
  15. Graham TE, Sgro V, Friars D, Gibala MJ. Glutamate ingestion: the plasma and muscle free amino acid pools of resting humans. Am J Physiol. 2000;278:E83–E89
  16. Heidbreder CA, Bianchi M, Lacroix LP, Faedo S, Perdona E, Remelli R, et al. Receptor 5 antagonist MPEP may act as an inhibitor of the norepinephrine transporter in vitro and in vivo. Synapse. 2003;50:269–276
  17. Hicks GA, Coldwell JR, Schindler M, Ward PA, Jenkins D, Lynn PA, et al. Excitation of rat colonic afferent fibers by 5-HT(3) receptors. J Physiol. 2002;544:861–869
  18. Hudson LJ, Bevan S, McNair K, Gentry C, Fox A, Kuhn R, et al. Metabotropic glutamate receptor 5 upregulation in A-fibers after spinal nerve injury: 2-metyhl-6-(phenylethynyl)-pyridine (MPEP) reverses the induced thermal hyperalgesia. J Neurosci. 2002;22:2660–2668
  19. Jensen J, Lehmann A, Uvebrant A, Carlsson A, Jerndal G, Nilsson K, et al. Transient lower esophageal sphincter relaxations in dogs are inhibited by a metabotropic glutamate receptor 5 antagonist. Eur J Pharmacol. 2005;519:154–157
  20. Käll E, Lindström E, Martinez V. The serotonin reuptake inhibitor citalpram does not affect colonic sensitivity or compliance in rats. Eur J Pharmacol. 2007;570:203–211
  21. Karim F, Wang CC, Gereau RW IV. Metabotropic glutamate receptor subtypes 1 and 5 are activators of extracellular signal-regulated kinase signaling required for inflammatory pain in mice. J Neurosci. 2001;21:3771–3779
  22. Laird JMA, Martinez-Caro L, Garcia-Nicas E, Cervero F. A new model of visceral pain and referred hyperalgesia in the mouse. Pain. 2001;92:335–342
  23. Lynn PA, Blackshaw LA. In vitro recordings of afferent fibers with receptive fields in the serosa, muscle and mucosa of rat colon. J Physiol. 1999;518:271–282
  24. Malherbe P, Kratochwil N, Zenner MT, Piussi J, Diener C, Kratzeisen C, et al. Mutational analysis and molecular modeling of the binding pocket of the metabotropic glutamate 5 receptor negative modulator 2-methyl-6-(phenylethynyl)-pyridine. Mol Pharmacol. 2003;64:823–832
  25. Martinez V, Thakur S, Mogil JS, Taché Y, Mayer EA. Differential effects of chemical and mechanical colonic irritation on behavioral pain response to intraperitoneal acetic acid in mice. Pain. 1999;81:179–186
  26. Munakata J, Naliboff B, Harraf F, Kodner A, Lembo T, Chang L, et al. Repetitive sigmoid stimulation induces rectal hyperalgesia in patients with irritable bowel syndrome. Gastroenterology. 1997;112:55–63
  27. Ness TJ, Gebhart GF. Colorectal distension as a noxious visceral stimulus: physiologic and pharmacologic characterization of pseudoaffective reflexes in the rat. Brain Res. 1988;450:153–169
  28. Ness TJ, Metcalf AM, Gebhart GF. A psychophysiological study in humans using phasic colonic distension as a noxious visceral stimulus. Pain. 1990;43:377–386
  29. Ness TJ, Gebhart GF. Inflammation enhances reflex and spinal neuron responses to noxious visceral stimulation in rats. Am J Physiol. 2001;280:G649–G657
  30. Neto FL, Schadrack J, Berthele A, Zieglgänsberger W, Tölle TR, Castro-Lopes JM. Differential distribution of metbotropic glutamate receptor subtype mRNAs in the thalamus of the rat. Brain Res. 2000;854:93–105
  31. Neugebauer V. Metabotropic glutamate receptors-important modulators of nociception and pain behaviour. Pain. 2002;98:1–8
  32. O’Leary DM, Movsesyan V, Vicini S, Faden AI. Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism. Br J Pharmacol. 2000;131:1429–1437
  33. Page AJ, Young RL, Martin CM, Umaerus M, O’Donnell TA, Cooper NJ, et al. Metabotropic glutamate receptors inhibit mechanosensitivity in vagal sensory neurons. Gastroenterology. 2005;128:402–410
  34. Pietraszek M, Sukhanov I, Maciejak P, Szyndler J, Gravius A, Wislowska A, et al. Anxiolytic-like effects of mGlu1 and mGlu5 receptor antagonists in rats. Eur J Pharmacol. 2005;514:25–34
  35. Reis HJ, Massensini AR, Prado MA, Gomez RS, Gomez MV, Romano-Silva MA. Calcium channels coupled to depolarization-evoked glutamate release in the myenteric plexus of guinea-pig ileum. Neuroscience. 2000;101:237–242
  36. Slattery JA, Page AJ, Dorian CL, Brierley SM, Blackshaw LA. Potentiation of mouse vagal afferent mechanosensitivity by ionotropic and metabotropic glutamate receptors. J Physiol. 2006;577:295–306
  37. Su X, Gebhart GF. Effects of tricyclic antidepressants on mechanosensitive pelvic nerve afferent fibers innervating the rat colon. Pain. 1998;76:105–114
  38. Swanson CJ, Bures M, Johnson MP, Linden A-M, Monn JA, Schoepp DD. Metabotropic glutamate receptors as novel targets for anxiety and stress disorders. Nat Rev. 2005;4:131–144
  39. Tammpere A, Brusberg M, Axenborg J, Hirsch I, Larsson H, Lindström E. Evaluation of manometric recordings as pseudo-affective responses to noxious colorectal distension in rat. Pain. 2005;116:220–226
  40. Tao YX, Li YQ, Zhao ZQ, Johns RA. Synaptic relationship of the neurons containing a metabotropic glutamate receptor, mGluR5, with nociceptive primary afferent and GABAergic terminals in rat spinal superficial laminae. Brain Res. 2000;875:138–143
  41. Valerio A, Rizzonelli P, Paterlini M, Moretto G, Knopfel T, Kuhn R, et al. mGluR5 metabotropic glutamate distribution in rat and human spinal cord: a developmental study. Neurosci Res. 1997;28:49–57
  42. Varty GB, Grilli M, Forlani A, Fredduzzi S, Grzelak ME, Guthrie DH, et al. The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles. Psychopharmacology. 2005;179:207–217
  43. Walker K, Bowes M, Panesar M, Davis A, Gentry C, Kesingland A, et al. Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function. I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain. Neuropharmacology. 2001;40:1–9
  44. Walker K, Reeve A, Bowes M, Winter J, Witherspoon G, Davis A, et al. mGlu5 receptors and nociceptive function. II. mGlu5 receptors functionally expressed on peripheral sensory neurones mediate inflammatory hyperalgesia. Neuropharmacology. 2001;40:10–19
  45. Young RL, Page A, O’Donnell TA, Cooper NJ, Blackshaw LA. Peripheral versus central modulation of gastric vagal pathways by metabotropic glutamate receptor 5. Am J Physiol. 2007;292:G501–G511
  46. Zhu CZ, Wilson SG, Mikusa JP, Wismer CT, Gauvin DM, Lynch JJ, et al. Assessing the role of metabotropic glutamate receptor 5 in multiple nociceptive modalities. Eur J Pharmacol. 2004;506:107–118
  47. Zhu CZ, Hsieh G, El-Kouhen O, Wilson SG, Mikusa JP, Hollingsworth PR, et al. Role of central and peripheral mGluR5 receptors in post-operative pain in rats. Pain. 2005;114:195–202

PII: S0304-3959(07)00517-9

doi: 10.1016/j.pain.2007.09.008

PAIN
Volume 137, Issue 2 , Pages 295-305 , 15 July 2008

Article Tools

* Image Usage & Resolution